1 / 30

Management of Rheumatoid arthritis, Osteoarthritis & Gout

Management of Rheumatoid arthritis, Osteoarthritis & Gout. Dr. Eoin Casey MD FRCPI, FRCP. Background Reading. Davidson’s Principles & Practice of Medicine, 50 th Anniversary Ed, 2002 Musculoskeletal disorders, Ch 20: pg 957-1047

solana
Télécharger la présentation

Management of Rheumatoid arthritis, Osteoarthritis & Gout

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Management of Rheumatoid arthritis, Osteoarthritis & Gout Dr. Eoin Casey MD FRCPI, FRCP

  2. Background Reading • Davidson’s Principles & Practice of Medicine, 50th Anniversary Ed, 2002 • Musculoskeletal disorders, Ch 20: pg 957-1047 • Clinical Assessment of the Musculoskeletal System (handbook) Arthritis and Rheumatism Council UK http://www.arc.org.uk/about_arth/opubs/6321/6321.pdf

  3. General Assessment • History • Clinical examination • Functional anatomy • Physiology • Investigations • Major manifestations of musculoskeletal disease

  4. Symptoms & Signs • Joint pain • Stiffness • Swelling • Inflammation • Skin changes • Muscle changes • Deformity • Non-specific systemic symptoms (weight↓; appetite↓; energy ↓; concentration ↓; mood ↓)

  5. Osteoarthritis Aetiology is unknown

  6. Aims of management • Educate the patient • Control pain • Optimise function • Beneficially modify the disease process

  7. “It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has.” William Osler 1849-1919

  8. Management of OA • Patient’s personality • Attitude • Holistic factors - activities of daily living - co-morbid disease • Availability, cost & logistics of evidence-based intervention

  9. Patient education • Randomized controlled trials have shown that education results in substantial improvement and prolonged benefit

  10. Management of OA • Exercise - aerobic fitness - local strengthening exercises • Weight reduction • Simple analgesia - eg Paracetamol 1g 4-6 hrly • Non-steroidal anti-inflammatory drugs - (NSAIDS)

  11. NSAIDS • >40 NSAIDS available in Ireland • Top most prescribed drugs in the world • In favour of their use are - effectiveness - lack of toxicity - affordability • Variable individual tolerance and response • Non-responders to one agent may improve with another

  12. NSAIDS • Mechanism of Action - ↓ prostaglandin levels - inhibit cyclooxygenase (COX)

  13. Cyclo-oxygenase isoforms • COX I - housekeeping enzyme - expressed in gastric mucosa, platelets & kidney • COX II - inflammatory enzyme - expressed in various tissues largely at sites of inflammation

  14. The COX II controversy

  15. Selective COX II inhibitors

  16. Gastric side effects of NSAIDS • GIT toxicity - up to 30% • Aetiological factor in 30% gastric ulcers • 10% of RA/OA patients hospitalised annually for NSAID associated bleeding • Endoscopic evidence of ulceration in 20% of NSAID users even in absence of symptoms • 2000 deaths per annum in UK

  17. Risk factors for NSAID gastritis • Age > 60 years • Past history of PUD • Past history of adverse effects with NSAIDS • Steroid use • High doses • Multiple NSAIDS • Specific NSAIDS eg Indomethacin, Azapropazone • ↓risk - Proton pump inhibitors; Ranitidine • Cyto-protection with Mesoprostil

  18. NSAIDS side effects • Older people are at greatest risk for - renal - cardiovascular - GIT toxicity

  19. Other treatment modalities • Nutri-pharmaceuticals - Glucosamine - Chondroitin Sulphate • Topical agents • Physiotherapy • Occupational therapy

  20. Rheumatoid arthritis Aetiology is unknown

  21. Approach to management • Holistic approach to assessment • Education is as important as medications • NSAIDS • Corticosteroids • Disease modifying agents (slow acting)

  22. Steroids in Rheumatoid Arthritis • Glucocorticoids in low doses <7.5mg daily are very effective to bridge the gap of the latent period before disease modifying drugs work • Local intra-articular steroid injections

  23. Disease modifying agents • Hydroxychloroquine • Salazopyrine • Penicillamine • Gold • Methotrexate • Azathioprine • Luflunomide • Cyclophosphamide, Cyclosporine • Anti TNF agents eg Adalimumab (Humira), Etanercept (Embrel), Infliximab

  24. Non-drug treatments • Physiotherapy • Physical treatments • Surgery • Coping strategies

  25. Gout

  26. Gout • Crystal deposition • Negatively bi-refringent sodium monouric crystals in joints, bursa, tendons and kidney • Not always associated with hyperuricaemia

  27. Stages of Gout • 1. Acute Gout • 2. Inter critical periods • 3. Chronic tophaceous Gout

  28. Treatment of acute attack • One of the most painful conditions known • NSAIDS • Colchicine (main s/e diarrhoea) • Steroids

  29. Long term management • Uricosuric agents - Allopurinol 100mg od increasing to 300mg od - MOA: Xanthine oxidase inhibitor - 2-3 weeks after acute attack - initiation may precipitate an acute attack

  30. Gout in Older People • Association with thiazide diuretics • Increased toxicity to Allopurinol

More Related